Product Details

Clindamycin + Tretinoin 1% + 0.025% Cream/Ointment delivers a high-quality topical combination therapy formulated to Indian Pharmacopoeia (IP) standards. This fixed-dose combination manages acne vulgaris, combining antibacterial and retinoid-based comedolytic action in a single topical preparation.

The cream/ointment combines:

• Clindamycin Phosphate, a lincosamide antibiotic equivalent to Clindamycin that eliminates acne-causing bacteria by inhibiting bacterial protein synthesis, and
• Tretinoin, a first-generation topical retinoid that normalizes skin cell turnover and clears clogged pores by binding to retinoic acid receptors, reducing comedone formation.

Doctors commonly prescribe this combination for the topical treatment of acne vulgaris, particularly in cases involving both inflammatory and comedonal lesions. Hospitals, clinics, and pharmacies rely on this formulation for its consistent quality and dependable results. Our manufacturing process follows strict quality standards to guarantee high purity, accurate dosing, and reliable therapeutic efficacy in every batch.

Key Features

• IP-standard compliant topical combination therapy
• Treats acne vulgaris
• Delivers combined antibacterial and retinoid comedolytic action
• Contains Clindamycin Phosphate 1% + Tretinoin 0.025%
• Maintains a high-purity, stable formulation
• Convenient 15 g tube for topical application
• Suits hospital, clinical, and pharmacy use